About: Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	There was no statistical difference between gefitinib and vinorelbine in efficacy in chemotherapy-naïve, unselected elderly patients with advanced NSCLC, but there was better tolerability with gefitinib. Individuals who were EGFR FISH-positive benefited more from vinorelbine than from gefitinib. There was no statistical difference between gefitinib and vinorelbine in efficacy in chemotherapy-naïve, unselected elderly patients with advanced NSCLC, but there was better tolerability with gefitinib. Individuals who were EGFR FISH-positive benefited more from vinorelbine than from gefitinib. (en) Nebyl pozorován statistický rozdíl v efektu chemoterapie gefitinibem a vinorelbinem u pacientů vyššího věku s pokročilým nemalobuněčným karcinomem plic, ale byla zaznamenána lepší tolerance gefitinibu. Při léčbě EGFR FISH-pozitivních osob bylo lepších výsledků dosažno při použití vinorelbinu než gefitinibu. (cs)
Title	Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. Gefitinib versus vinorelbine v chemoterapii pacientů vyššího věku s pokročilým nemalobuněčným karcinomem (INVITE) : randomizovaná studie fáze II (cs) Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. (en)
skos:prefLabel	Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. Gefitinib versus vinorelbine v chemoterapii pacientů vyššího věku s pokročilým nemalobuněčným karcinomem (INVITE) : randomizovaná studie fáze II (cs) Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. (en)
skos:notation	RIV/00064211:_____/08:#0000028!RIV09-MZ0-00064211
http://linked.open...avai/riv/aktivita	V Z
http://linked.open...avai/riv/aktivity	V, Z(MZ00000064211)
http://linked.open...iv/cisloPeriodika	26
http://linked.open...vai/riv/dodaniDat	2009
http://linked.open...aciTvurceVysledku	Zatloukal, Petr
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Nemocnice Na Bulovce
http://linked.open...dnocenehoVysledku	368989
http://linked.open...ai/riv/idVysledku	RIV/00064211:_____/08:#0000028
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	gefitinib; vinorelbin; non-small-cell lunf cancer (en)
http://linked.open.../riv/klicoveSlovo	gefitinib vinorelbin non-small-cell lunf cancer
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[CA5F354FBD71]
http://linked.open...i/riv/nazevZdroje	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
http://linked.open...in/vavai/riv/obor	FC
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	14 (xsd:int)
http://linked.open...UplatneniVysledku	2008
http://linked.open...v/svazekPeriodika	26
http://linked.open...iv/tvurceVysledku	Pešek, Miloš Zatloukal, Petr Reck, Martin Cullen, Michael Armour, Alison A. Cappuzzo, Frederico Crino, Lucio Duffield, Emma Ford, Hugo Ghiorghiu, Serban Hirsch, Fred Speak, Georgina Thomson, Joyce C. Varella-Garcia, Marileila
http://linked.open...ain/vavai/riv/wos	000259350400006
http://linked.open...n/vavai/riv/zamer	Diferenciace, apoptosa a regulace transkripce u buněk zhoubných nádorů
issn	0732-183X
number of pages	8 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software